A clinical study of JZP 385 modified release formulation
Latest Information Update: 07 Aug 2020
At a glance
- Drugs Suvecaltamide (Primary)
- Indications Epilepsy; Essential tremor; Neuropathic pain
- Focus Adverse reactions
- 07 Aug 2020 New trial record
- 04 Aug 2020 According to a Jazz Pharmaceuticals media release, the company is initiating this study in August 2020.